The Rickeffsia prowazekii ATP/ADP translocase was identified by sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis (PAGE) and immunoblot analysis using antibodies raised against a synthetic peptide corresponding in sequence to the carboxyl-terminal 17 amino acids of the carrier. Both the translocase of R. prowazekii and that expressed by Escherichia coli transformants containing the rickettsial gene had an apparent molecular mass of 36,500 Da by SDS-PAGE analysis, a mass considerably less than that deduced from the sequence of the gene. The SDS-solubilized translocase aggregated upon heating at 100°C in the presence of disulfide bond-reducing agents. Similar concentrations of disulfide bond-reducing agents inhibited the exchange transport of adenine nucleotides by both R. prowazekii and translocase-expressing E. coli. These data suggested that an intramolecular disulfide bond in the translocase was essential for transport activity. The antipeptide antibodies used for identification of the translocase bound preferentially to inside-out membrane vesicles of translocase-expressing E. coli relative to right-side-out spheroplasts, thus indicating that the carboxyl terminus of the carrier is located on the cytoplasmic side of the bacterial inner membrane. Protease studies were unable to localize the carboxyl terminus because of the resistance of this region of the native translocase to proteolytic cleavage. These data in conjunction with hydrophobicity analysis were used to construct an initial topological model of the translocase within the cell membrane.
The obligate intracytoplasmic bacterium Rickettsia prowazekii, the etiologic agent of the human disease epidemic typhus, grows and multiplies only within the cytoplasm of a eucaryotic cell. This cytoplasm contains metabolites normally unavailable to free-living bacteria, and the rickettsiae have evolved mechanisms to transport many of these large, charged metabolites directly from the host cell's cytoplasmic pools. Such transport systems are very unusual and have never been described in free-living bacteria. R. prowazekii has been shown to transport uridine 5'-diphosphoglucose (41) , NAD (3), AMP (2) , and ADP and ATP (38) .
The rickettsial ATP/ADP translocase is an obligate exchange transport system specific for ADP and ATP, so that for every ATP transported into the rickettsiae an ADP molecule must be expelled (38) (39) (40) . The net result of this exchange is the transport of a high-energy phosphate bond into the rickettsial cell. The gene coding for the R. prowazekii ATP/ADP translocase (tlc gene) has been cloned and expressed in Escherichia coli (23) , and the rickettsial translocase has been reconstituted into proteoliposomes (27) . The translocation properties of both the cloned gene product and the reconstituted system are the same as those of the translocase in rickettsiae. Analysis of the DNA sequence of the cloned gene revealed a single large open reading frame (ORF) predicted to code for a hydrophobic protein with a molecular mass of 56,668 Da and an isoelectric point of 10.3 (37) .
It is interesting that mitochondria possess an analogous system for the exchange of ADP and ATP (21) . However, the physiological direction of the exchange is opposite that found in the rickettsiae: the mitochondrial ADP/ATP translocase predominantly catalyzes the exchange transport of cytoplasmic ADP for mitochondrial matrix ATP to serve the * Corresponding author.
interests of the eucaryotic cell rather than to parasitize it. The mitochondrial transport system is sensitive to specific inhibitors, such as carboxyatractyloside (36) and bongkrekic acid (17, 18, 22) , none of which have shown an effect on the rickettsial ATP/ADP transport system (27, 38) . In addition, comparisons of the highly conserved nucleotide and amino acid sequences of several mitochondrial translocases with those of the rickettsial translocase revealed no homologies (37) .
Attempts to identify the product of the tlc gene have been largely unsuccessful, presumably because of the poor expression of the tlc gene in E. coli (28) . The identification and characterization of the ATP/ADP translocase will be an important step toward understanding the mechanism of ATP/ADP translocation in R. prowazekii. In this study, polyclonal antibodies against a synthetic peptide, corresponding in sequence to the predicted carboxyl-terminal 17 amino acids of the rickettsial ATP/ADP translocase, allowed the identification and characterization of the protein product of the tlc gene in the membrane fraction of translocaseexpressing E. coli and of R. prowazekii. These data, in conjunction with DNA sequence data, were used to construct an initial topological model of the ATP/ADP translocase in the bacterial inner membrane.
MATERIALS AND METHODS
Preparation of bacteria and plasmids. R. prowazekii, Madrid E strain, was propagated in 6-day embryonated, antibiotic-free hen eggs by inoculation with a dilution of a seed pool. Infected yolk sacs were harvested 8 days postinoculation, and rickettsial suspensions were prepared from heavily infected yolk sacs and further purified at 4°C as previously described (38) .
E. coli strains were grown at 37°C in L broth (10) Sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis (PAGE), electrotransfer, and immunostaining of blotted proteins. Proteins were solubilized in 2.5% SDS, 0 to 10% BME or DTT, 1 mM EDTA, and 10 mM Tris-HCl, pH 8.0. Electrophoresis was performed with 10 to 15% gradient polyacrylamide gels on the Phastsystem electrophoresis system (Pharmacia-LKB). The gels were equilibrated in transfer buffer (3 mM Na2CO3, 10 mM NaHCO3, pH 10.2, 20% methanol, 0.1% SDS) (11, 35) and electrotransferred to Immobilon transfer membranes (Millipore) in a Trans-Blot unit (Bio-Rad Laboratories, Richmond, Calif.) at 125-mA constant current for 40 min at room temperature. The membranes were blocked with 4% BSA in Tris-buffered saline (TBS; 20 mM Tris-HCl, pH 7.4, 150 mM NaCl) for 30 min at 37°C, washed three times with 0.1% BSA in TBS, and incubated with the antipeptide antibody preparation diluted 1:1,000 in antibody incubation solution (TBS, 1% BSA, 0.05% Tween 20) for 2 h at 37°C with gentle agitation. To reduce the intensity of nonspecific background staining, the antipeptide antibody preparation was preadsorbed with an MOB483 extract (final protein concentration, approximately 1 mg/ml) for 1 h at 4°C. After incubation with the first antibody, the membranes were washed and incubated with alkaline phosphatase-labeled goat anti-rabbit immunoglobulin G (Sigma) diluted 1:1,000 in antibody incubation solution for 2 h at 37°C. The membranes were washed three times, and specifically bound antibodies were visualized with the 5-bromo-4-chloro-3-indolyl phosphate and nitroblue tetrazolium substrate system (Kirkegaard & Perry Laboratories, Inc., Gaithersburg, Md.).
Immunoprecipitation of the ATP/ADP translocase. A pellet of isolated membranes (approximately 2 mg of total protein) from R. prowazekii was solubilized with 100 pI of 10 mM Tris-HCl, pH 8.0, containing 1 mM EDTA and 1% SDS. Insoluble material was removed by centrifugation at 16,000 x g for 10 min at room temperature. The solubilized proteins were diluted into 500 ,ul of buffer TD (10 mM Tris-HCl, pH 8.0, 0.85% NaCl, 0.1% SDS, 0.5% sodium deoxycholate, 0.5% Triton X-100) and 50 [L of the antipeptide antibody preparation or 50 RI of anti-R. prowazekii antiserum, mixed, and incubated at 4°C overnight. A suspension of protein A-Sepharose 4B-CL (34 mg; Pharmacia-LKB) was added to the antigen-antibody solution and incubated with mixing for 1 h at 4°C. The complex was collected by centrifugation at 16,000 x g for 10 min at room temperature, washed three times with buffer TD, and resuspended in 2.5% SDS-5.0% BME-1 mM EDTA-10 mM Tris-HCl, pH 8.0. After centrifugation, the supernatant fluid was analyzed by SDS-PAGE and immunoblotting.
Binding of antibody to and proteolytic digestion of spheroplasts and ISO membrane vesicles. Spheroplasts were prepared from strains MOB384 and MOB385 grown to mid-log phase in L broth plus ampicillin (20) . ISO membrane vesicles were prepared by controlled lysis of spheroplasts by a single pass at 7,000 lb/in2 through a French press (13, 14) . Residual intact cells were removed by centrifugation at 14,000 x g for 10 min at 4°C. Spheroplasts and ISO membrane vesicles were used immediately without freezing to determine the sidedness and protease accessibility of the carboxyl terminus.
Spheroplasts and ISO membrane vesicles were suspended without washing to a final total protein concentration of approximately 1.0 mg/ml in TBS buffer containing 25% identify and characterize the ATP/ADP translocase. An immunoreactive protein band, migrating with an apparent molecular mass of 36,500 Da, was found in the membrane fraction of MOB384 (a translocase-expressing E. coli strain) and R. prowazekii by immunoblot analysis (Fig. 1) . No corresponding immunoreactive band was identified in the membrane of the negative control E. coli MOB385 or in the soluble fractions of any of the organisms. No band corresponding to the immunostained band was identified in the silver-stained gel.
The ATP/ADP translocase was immunoprecipitated from solubilized membranes of R. prowazekii with the antipeptide antibody preparation, separated by SDS-PAGE, and visualized by silver staining or immunoblot analysis (Fig. 2) . A 36,500-Da band was identified both in the silver-stained gel ( Fig. 2A) and in the immunoblot analyzed (Fig. 2B) heavy chain of the precipitating rabbit immunoglobulin, as expected, was also seen on the immunoblot. The ATP/ADP translocase was not immunoprecipitated by the antiserum against whole R. prowazekii, indicating the sparsity of anti-ATP/ADP translocase antibodies in this antiserum (Fig. 2) . These data indicate that the 36,500-Da immunoreactive band is the rickettsial ATP/ADP translocase and that it is found in the membrane fraction of the translocase-expressing E. coli strain MOB384 and R. prowazekii.
Effect of disulfide bond-reducing agents on aggregation of the ATP/ADP translocase. Electrophoretic analysis of proteins solubilized by heating in a boiling water bath for 1 to 5 min in the presence of SDS and a disulfide bond-reducing agent, such as BME, is a standard procedure for separating proteins on the basis of molecular weight (24) . However, attempts to analyze rickettsial membrane samples by this technique resulted in the complete aggregation of the translocase and its failure to enter the separating portion of an SDS-polyacrylamide gel (Fig. 3) . Aggregation of the translocase was more pronounced as the time of sample heating increased, with complete aggregation of the translocase occurring at 5 min. Rickettsial membrane samples that were solubilized at room temperature showed no aggregation of the translocase. In addition, the translocase did not aggregate upon heating if the disulfide bond-reducing agent was omitted from the solubilization buffer. A concentration of either 5% DTT or 5% BME was sufficient to promote aggregation of the translocase upon heating; however, 1% DTT or 1% BME was insufficient to promote the aggregation phenomenon. As a control for the specific disulfide bondreducing functions of BME and DTT, chemically similar but nonreducing analogs (butanediol, trans-4,5-dihydroxy-1,2-dithiane, threitol, and ethylene glycol) were added at a 10% concentration. Addition of the less polar analogs, butanediol and trans-4,5-dihydroxy-1,2-dithiane, caused aggregation when the samples were heated: on the other hand, addition of the more polar analogs, threitol and ethylene glycol, did not cause aggregation.
Effect of disulfide bond-reducing agents on the transport activity of the ATP/ADP translocase. The addition of high concentrations (5% or 10% BME or DTT) of disulfide bond-reducing agents to translocase-expressing E. coli or to R. prowazekii completely inhibited the translocation of ATP, while lower concentrations (1% BME or 1% DTT) had little effect on ATP transport (Fig. 4) 4 . Effects of BME and DTT on the uptake of ATP by R. prowazekii and translocase-expressing E. coli. The uptake of ATP at 10 min by R. prowazekii (E) and E. coli MOB603 (e) and MOB483 (0) in the presence of the indicated concentration of disulfide bond-reducing agent was determined. Control values were determined in the absence of disulfide bond-reducing agents. The effect of removal of disulfide bond-reducing agents from BME-or DTTtreated MOB603 upon ATP transport is presented as follows: CTL-BME, initially treated without disulfide bond-reducing agents and then treated with 5% BME; BME-BME, 5% BME treatment followed by 5% BME treatment; BME-CTL, 5% BME treatment followed by treatment without disulfide bond-reducing agents; CTL-DTT, initially treated without disulfide bond-reducing agents and then treated with 5% DTT; DTT-DTT, 5% DTT treatment followed by 5% DTT treatment; DTT-CTL, 5% DTT treatment followed by treatment without disulfide bond-reducing agents. The error bars indicate the standard deviation for duplicate time points.
reversed by sedimentation of the treated cells and resuspension of these cells in medium without the agents (Fig. 4) . Since the activity of the ATP/ADP translocase is not inhibited by metabolic poisons, dissipation of the membrane potential, or N-ethylmaleimide (NEM) (38) , secondary effects of BME or DTT on the translocase are unlikely. Furthermore, none of the chemically similar but nonreducing analogs (butanediol, threitol, and ethylene glycol) appreciably inhibited transport (trans-4,5-dihydroxy-1,2-dithiane is insoluble in aqueous buffers and could not be tested). These data suggest that maintenance of a disulfide bond in the translocase is necessary for the proper functioning of the transport system and that the removal of the reducing agent leads to the restoration of this critical disulfide bond and transport activity.
Determination of the protease accessibility of the carboxyl terminus of the translocase in spheroplasts and ISO vesicles of MOB384. Spheroplasts which maintain a right-side-out (RSO) orientation (42) and high-pressure lysis membrane vesicles which are largely oriented ISO (13, 14) were prepared from the translocase-expressing E. coli strain MOB384, treated with chymotrypsin or proteinase K, and subjected to SDS-PAGE and immunoblotting with the anti-FCO CONTROL CONTROL 1%BME 5% BME 10% BME 1% DTr 5% DTT-10% D-T CTL-BME BME-BME BME-CTL peptide antibody preparation (Fig. 5) . In both vesicle preparations, protease treatment hydrolyzed the translocase so that the 36,500-Da band was absent. Furthermore, lowmolecular-weight carboxyl-terminal peptide fragments were generated that were still reactive with the antibodies but were too small to allow accurate molecular weight determinations in the gel system used. Although the carboxylterminal epitopes recognized by the antipeptide antibodies were not susceptible to proteolytic degradation in spheroplasts or ISO membrane vesicles, complete degradation of the immunoreactive portion of the translocase by chymotrypsin or proteinase K was readily demonstrated in the membrane preparations solubilized by 1% Triton X-100 (data not shown). The resistance of the carboxyl-terminal region to proteolytic degradation in native membranes in either orientation prevented us from obtaining topological data by this technique.
CTL-DTT
Antipeptide antibody binding to spheroplasts and ISO vesicles of MOB384 and MOB385. The binding of antipeptide antibodies to spheroplasts and ISO membrane vesicles of translocase-expressing E. coli was measured to determine the accessibility and hence location of the carboxyl terminus. ISO membrane vesicles prepared from the translocaseexpressing E. coli strain MOB384 that were probed with the antipeptide antibody and '25I-protein A bound at least eight times more radioactivity than did the RSO spheroplasts (Fig.  6 ). Neither spheroplasts nor ISO vesicles prepared from the negative control E. coli MOB385 bound significant amounts of radioactivity. These data indicate that the carboxyl terminus of the translocase is exposed on the cytoplasmic face of the inner membrane.
The accessibility of the carboxyl-terminal region to antipeptide antibodies in ISO membrane vesicles was intriguing since this region appeared to be inaccessible to proteases in identical preparations. Protease-treated ISO membrane vesicles were probed with antipeptide antibodies and 1251_ protein A to determine whether the epitopes recognized by the antipeptide antibodies had been hydrolyzed (Fig. 6) . The antipeptide antibodies bound to both protease-treated and control MOB384 ISO membrane vesicles in equal amounts. As expected, the antipeptide antibody did not bind to protease-treated MOB385 ISO membrane vesicles. These data indicate that the antipeptide antibody has accessibility to a protease-resistant region of the carboxyl terminus of the ATP/ADP translocase.
DISCUSSION
Antibodies to a 17-amino-acid synthetic peptide, representing the deduced carboxyl-terminal sequence of the rickettsial ATP/ADP translocase, were used to identify the translocase in immunoblots of translocase-expressing E. coli strains and R. prowazekii. This immunostained band was found only in the membrane fraction of E. coli transformants containing the rickettsial tlc gene and in R. prowazekii itself and had an apparent molecular mass of 36,500 Da by SDS-PAGE analysis. Similarly, when the translocase was immunoprecipitated from SDS-solubilized R. prowazekii membranes with the antipeptide antibody preparation and protein A-Sepharose, a single polypeptide band with the same apparent molecular mass was identified in both silverstained and immunostained preparations.
Analysis of the translocase by standard SDS-PAGE and immunoblotting techniques was complicated by the atypical behavior of this protein. The The translocase aggregated upon heating in the presence of 5 to 10% BME or DTT but did not aggregate when the concentration was reduced to 1% or less. A related phenomenon has been reported for the P-adrenergic receptors of eucaryotic cells, in which the presence of intramolecular disulfide bridges in the receptor was established by demonstrating that chemical reduction of these bonds decreased the electrophoretic mobility of these proteins (25, 26) . On the other hand, the temperature-dependent formation of highmolecular-weight complexes in the presence of BME has also been reported for the cystineless reaction center proteins of Rhodopseudomonas sphaeroides (32) . Thus, these data do not unambiguously indicate that the reduction of a disulfide bond in the ATP/ADP translocase results in a conformational change that predisposes the translocase to denaturation and aggregation upon heating.
However, the data strongly suggest that a disulfide bond within the membrane is necessary for maintaining the carrier in an active conformation. The translocation of ATP was inhibited by high concentrations of reducing agents but was not inhibited by the nonreducing analogs of these agents. Interestingly, analysis of the predicted amino acid composition of the ATP/ADP translocase revealed the presence of only two cysteines in the coding region for this protein (Cys-37 and Cys-85). Reduction of this single intramolecular disulfide bridge may result in an unfolding of the detergentsolubilized protein which exposes hydrophobic domains that can interact to form a large, insoluble aggregate. In addition to predisposing the solubilized translocase to heat denaturation and aggregation, the destabilization of the native translocase may interfere with substrate binding or with the translocation process itself.
The inhibition of adenine nucleotide translocation by disulfide bond-reducing agents was readily reversed by the removal of the reducing agent from the inhibited cells. The sulfhydryl alkylating reagent NEM was unable to prevent the reversal of inhibition upon removal of the reducing agent, presumably because of its inability to reach the susceptible sulfhydryl groups prior to reoxidation and reformation of a disulfide bond. NEM had no effect on ATP transport, which indicates that accessible, free sulfhydryls were not essential for translocase activity. The high concentrations of disulfide bond-reducing agent required to inhibit the translocation process indicate that the disulfide bond of the translocase is relatively resistant to reduction when native and within the lipid bilayer.
The value of 36,500 Da estimated from immunoblots and immunoprecipitations differs considerably from that of 56,668 Da calculated from the DNA sequence data (37) . In theory, proteolysis could have occurred, but would be limited to removal of the first 36 amino acids (to retain Cys-37 for the disulfide bond) and the last 10 to 13 amino acids at the carboxyl terminus (to retain the amino acids necessary for an epitope). This truncated protein would still be greater than 50 kDa. The most likely explanation is that the apparent low-molecular-weight value by SDS-PAGE analysis is due to excessive binding of SDS to hydrophobic regions of the protein, a phenomenon that is not uncommon with hydrophobic membrane proteins (6, 8, 9) .
The use of impermeant, high-molecular-weight probes, such as antibodies and proteases, to obtain information on the orientation of membrane-spanning polypeptide chains is an important tool for determining the topological arrangement of an integral membrane protein. An attractive approach for determining the orientation of a membrane protein bilayer is to synthesize peptides on the basis of the deduced sequence and raise antibodies to those peptides which correspond to specific hydrophilic portions of the protein. In the literature, such site-directed antibodies have localized the reactive epitopes at either side of the membrane. A carboxyl-terminal sequence was chosen for the synthesis of a peptide for both the lactose carrier and the melibiose carrier of E. coli (5, 31) . Site-directed antibodies produced against these peptides bound only to the surface of ISO vesicles and not to RSO vesicles, indicating that the carboxyl terminus of both of these proteins is exposed on the cytoplasmic face of the membrane (5, 31 (37) , predicts 12 hydrophobic alpha-helical transmembrane regions, with 13 extramembrane hydrophilic extensions connecting the transmembrane regions (Fig. 7) . The model is presented with the carboxyl terminus in a cytoplasmic orientation as directed by the antipeptide antibody binding data. A disulfide bond is indicated between the cysteine residue at position 37 and the cysteine residue at position 85, which are presumed to be located between the first two transmembrane regions. The large number of charged groups in the extramembrane domains provide a hydrophilic region for interaction with the aqueous phase and with substrates. This model of the ATP/ADP translocase is similar to that predicted for a number of other transport proteins from both procaryotes and eucaryotes. In each case, the model suggests a hydrophobic integral membrane protein, usually with 12 transmembrane segments, and a cytoplasmic extramembrane domain of significant size. These proteins, which include the lactose permease (12) , are suggested to function as monomers, as opposed to a related group of carriers which possess six transmembrane segments and appear to function as dimers (1, 29) . This second class of carriers includes the mitochondrial ATP/ADP translocase (4) and several other mitochondrial and chloroplast transport systems. Interestingly, a full complement of 12 membrane-spanning segments often appears to be necessary for functional transport activity. The conformation of this general design requires more detailed investigations of transmembrane topology and eventually the construction of definitive models based on X-ray crystallographic studies.
